Explore educational content from VCCC lectures, symposia and conferences to keep abreast of the latest developments.
Monday 29 July 2019
Monday Lunch Live with Michael Dickinson, Haematologist, Lead of the Aggressive Lymphoma Team, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital.
Dr Dickinson discusses Chimeric Antigen Receptor T-cells and the expanded research opportunities following the regulatory approval of commercially-manufactured CAR T-cell treatments. He is joined by Finnian Kenny who took part in a CAR T-cell trial with good outcomes.
Monday 06 May 2019
Monday Lunch Live with presenters Karen Botting, Department of Health and Human Services, Victoria, and Mei Krishnasamy, The University of Melbourne and VCCC.
This project was undertaken to refresh the supportive care and resources available to clinicians and organisations.
Karen and Mei discuss the official launch of WeCan, the result of the Supportive Care in Cancer Refresh Project, and outline the framework of the project slong with its new resources.
Monday 20 May 2019
Monday Lunch Live with presenters Alesha Thai and George Au-Yeung, Peter MacCallum Cancer Centre
International Clinical Trials Day.
To celebrate International Clinical Trials Day, Alesha and George share insight into their principal investigator experiences. Encompassing the challenges of a first trial, learnings and achievements gained.
Monday 13 May 2019
Monday Lunch Live with presenters Ann Maree Keenan, Safer Care Victoria, Theresa Wiseman, University of Southampton, Mei Krishnasamy, The University of Melbourne and VCCC, and Paul Baden, VCCC
International Nurses Day.
In celebration of International Nurses Day, this event showcases how nurse-led research improves quality and safety of cancer care and clinical outcomes
Monday 29 April 2019
Monday Lunch Live with presenters Maria Kavallaris, Children's Cancer Institute and UNSW Sydney, and John McGhee, 3D Visualisation Aesthetics Lab and UNSW Sydney.
Nanomedicine for Cancer Therapy.
John and Maria will delve into the pre-clinical trial studies on nanoparticle drug delivery systems and the promise of new forms of targeted cancer treatment. They will also discuss the use of virtual reality platforms and biomedical imaging methods such as fluorescence microscopy and serial block-face scanning electron microscopy.
Monday 18 March 2019
Monday Lunch Live with presenter Suzanne Garland, The Women’s and The Royal Children's Hospital.
Internationally recognised clinical microbiologist and sexual health physician with particular expertise in infectious diseases related to reproductive health and the neonate.
Suzanne shares how Australia will likely become the first country to effectively eliminate cervical cancer.
Monday 01 April 2019
Monday Lunch Live with presenter Chris Paul, University of Newcastle.
Chris discusses Impact of financial costs of cancer on patients – the Australian experience. and is joined by Denise Beovich and Tegan Murnane, Senior Social Workers at Peter MacCallum Cancer Centre, who will provide a brief case study outlining the significant financial effects. Consumer advocates Sophy Athan and Paul Baden will then provide patient perspectives from a financially toxic experience and financially neutral experience.
Monday 04 March 2019
Monday Lunch Live with presenter Helen Johnson, Christie Hospital, Manchester UK.
Paving the way for community based cancer care.
Specialising in prostate cancer with a special interest in survivorship, Helen will discuss how The Christie team have developed a new and innovative patient pathway to ensure that prostate cancer follow up is delivered in a safe, effective and sustainable way which is acceptable to all.
Monday 11 February 2019
Monday Lunch Live with presenter Rami Rahal, Executive Director of the Cancer Control at the Canadian Partnership Against Cancer (CPAC).
Combining expertise in healthcare management information, quality measurement and evidence-based decision support.
Rami discusses how System Performance measurement has a lot of promise but has generally fallen short of realising its value. He providse a comprehensive approach for measurement to action, based on his experience in Canadian cancer control.
Monday 04 February 2019
Monday Lunch Live with presenters Clare Scott, Walter and Eliza Hall Institute, Kate Vines, Rare Cancers Australia, and research participant, Heather Camp.
The story of patient-led cancer research.
A story of patient-led cancer research exemplifies the power and importance of consumer activity in cancer research. Rare cancers collectively cause more cancer deaths in Australia than any single cancer type. Learn about the NOMINATOR trial, an innovative patient-driven clinical trial exploring genomic profiling of rare cancers.
Monday 25 March 2019
Monday Lunch Live with Dr Clare Fedele, science communicator, biochemist, scientist, researcher, NHMRC Early Career Fellowship, Peter MacCallum Cancer Centre.
The importance of good communication for regaining public trust in health and medical research.
Dr Fedele reveals some of the challenges associated with modern media with a lens on scammers, conspiracy theorists, true believers and wellness warriors. Learn about implications for sharing scientific information in a culture where everyone has a voice.
Monday 20 November 2017
Monday Lunch Live with presenters Elizabeth Sigston and Bryan Williams, Monash University
An emergence framework for carcinogenesis.
How do you believe cancer starts? How does that belief affect your research or even your clinical approach? Have your paradigms shifted as Elizabeth pulls previously irreconcilably theories together into a new framework of cancer development.
Monday 30 October 2017
Monday Lunch Live with presenter Prue Cormie, Australian Catholic University
Ex-Med Cancer: prescribing exercise, the cancer wonder-drug.
Ex-Med Cancer is a new program designed to counteract the adverse effects of cancer and its treatment through exercise medicine. Learn more about the research evidence and this safe, effective and feasible community based service from Prue.
Monday 23 October 2017
Monday Lunch Live with presenters Dirk Schadendorf, University Hospital Essen, and Jürgen Becker, Medical University of Graz.
Immunotherapies have made a major impact on skin cancer therapy but they have their limitations.
Leading international experts, Dirk Jürgen examine the immune escape mechanisms used by melanoma and merkel cell carcinoma, and ask ‘where next?’ for the immunotherapy approach.
Monday 16 October 2017
Monday Lunch Live with presenters Chandrajit P Raut, Brigham and Women's Hospital, and Dana-Farber, Harvard Medical School
Establishing a translational surgical research program in an academic cancer centre.
Chandrajit shares his experiences in stitching together tumour banks, databases, finances, mentorship, multiple disciplines and more to form the Dana-Farber Cancer Center's Translational Surgical Research Program.
Monday 09 October 2017
Monday Lunch Live with presenters Glenn Begley. BioCurate.
"10% of the time, it works every time".
Perverse scientific incentives drive our academic system and allow us to tolerate the sloppy, lazy, science that we see every week in the so-called “top tier” journals. Glenn asks if a highly-citied paper is always a high-quality paper. Shouldn’t we be focused on real-life impact factors?
Monday 02 October 2017
Monday Lunch Live with presenter Eyal Mishani, Hadassah Hebrew University Hospital, Jerusalem.
New frontiers in PET/CT molecular imaging: Lung and Prostate Cancers.
Overseeing the vibrant research and development program at Hadassah Hebrew University Hospital, Eyal delves into the new frontiers available in PET/CT molecular imaging, with a focus on lung and prostate cancers.
Collaborative Radiology Oncology Trials: Do or Die - Associate Professor Farshad Foroudi
President, Trans Tasman Radiation Oncology Group
Director, Austin Health Radiation Oncology
Investigating the contribution of alcohol in breast cancer recurrence and the way in which alcohol recommendations are discussed between clinicians and oncology patients - Dr Anna Boltong, VCCC Associate Director
Palliative Care: The science behind the art of care - Brian Le
Director of Palliative Care, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre
Creating a culture of autonomous innovation - Dr Amanda Caples, Lead Scientist of Victoria
Crisis, what crisis? Health care funding in the future - Stephen Duckett, Grattan Institute
Novel techniques for epigenomic profiling of single cells and circulating cell-free DNA - Lu Wen, Research Scientist (Co-Pl)
Dr Fuchou Tang's Lab in BIOPIC at Peking University, China
Differentiation therapy for colorectal cancer - John M. Mariadason, PhD
Oncogenic Transcription Laboratory, Olivia Newton-John Cancer Research Institute